Invacare 2014 Annual Report Download - page 89

Download and view the complete annual report

Please find page 89 of the 2014 Invacare annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 136

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136

INVACARE CORPORATION AND SUBSIDIAIRIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS-(Continued)
FS-19
The increase in the SERP liability in 2014 is the result of a reclassification of this liability from Other Long-Term Obligations
to Current Liabilities as a result of the retirement of four senior executive officers of the Company. The majority of this liability
is expected to be paid out by the end of the third quarter of 2015, which will negatively impact the operating cash flows of the
Company.
Accrued rebates relate to several volume incentive programs the Company offers its customers. The Company accounts for
these rebates as a reduction of revenue when the products are sold in accordance with the guidance in ASC 605-50, Customer
Payments and Incentives.
Generally, the Company's products are covered by warranties against defects in material and workmanship for various periods
depending on the product from the date of sales to the customer. Certain components carry a lifetime warranty. A provision for
estimated warranty cost is recorded at the time of sale based upon actual experience. The Company continuously assesses the
adequacy of its product warranty accrual and makes adjustments as needed. Historical analysis is primarily used to determine the
Company's warranty reserves. Claims history is reviewed and provisions are adjusted as needed. However, the Company does
consider other events, such as a product field action and recalls, which could warrant additional warranty reserve provision.
Changes in accrued warranty costs were as follows (in thousands):
2014 2013
Balance as of January 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 27,393 $ 21,451
Warranties provided during the period. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,472 10,831
Settlements made during the period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (22,752)(13,452)
Changes in liability for pre-existing warranties during the period, including expirations. . . . . . . 4,625 8,563
Balance as of December 31 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 30,738 $ 27,393
The Company's warranty expense for 2014 includes $11,493,000 for three specific product issues. First, an expense of
$6,559,000 for a recall related to a component in a stationary oxygen concentrator that was manufactured in the Company’s facility
in Suzhou, China, and sold globally, which is no longer used in production. This expense was recorded in the European segment
($3,395,000) and North America/HME segment ($3,164,000). Second, an expense of $2,057,000 for the recall of a sieve bed
component used within stationary oxygen concentrators manufactured during August 2014, which was recorded in the North
America/HME segment. Third, an incremental expense of $2,877,000 related to the Company's joystick recall as a result of higher
than previously anticipated response rates from larger customers in the U.S. and Canada and a shift in the product mix toward
higher cost joysticks, which was recorded in the North America/HME segment ($1,612,000) and the Asia/Pacific segment
($1,265,000). These warranty reserves are subject to adjustment in future periods as new developments change the Company's
estimate of the total cost of these matters.
The warranty expense for 2013 included an increase in warranty expense of $7,264,000 related to the power wheelchair
joystick recall, the impact of which was recorded in the Asia/Pacific ($4,639,000) and the North America/HME segment
($2,625,000).
Long-Term Debt
Debt as of December 31, 2014 and 2013 consisted of the following (in thousands):
2014 2013
Senior secured revolving credit facility, due in October 2015. . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 4,000 $ 28,109
Convertible senior subordinated debentures at 4.125%, due in February 2027. . . . . . . . . . . . . . . 11,351 10,641
Other notes and lease obligations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,993 6,536
20,344 45,286
Less current maturities of long-term debt. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (967)(14,102)
$ 19,377 $ 31,184
The Company had outstanding letters of credit of $7,063,000 and $6,422,000 as of December 31, 2014 and 2013, respectively.